# NAION Treatment With Oral Prednisolone and Erythropoietin Injection

> **NCT03715881** · PHASE2 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 99 (estimated)

## Conditions studied

- Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

## Interventions

- **DRUG:** Oral prednisolone administration 50 mg
- **DRUG:** Intravenous Erythropoietin injection

## Key facts

- **NCT ID:** NCT03715881
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03715881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03715881, "NAION Treatment With Oral Prednisolone and Erythropoietin Injection". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03715881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*